Singapore, SG, 14 May 2019 15:15 SGT/09:15 CEST
Royal DSM, a purpose-led global science-based company active in Nutrition, Health and Sustainable Living, announces global price increase for its Akulon® and Novamid® PA6 compounds.
The price increase is due to the manufacturing industry experiencing a continuous rise in overall costs of input materials. The increases are as follows:
The price increase is effective 01 June 2019 or as contracts allow.
Global Director Communications & External Affairs
+31 6 2096 3786